Related Experiment Video
Updated: Jun 16, 2026
05:25
Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Delayed malignant hyperthermia after routine coronary artery bypass
Michael Firstenberg1, Erik Abel, Danielle Blais
1Division of Cardiothoracic Surgery, The Ohio State University Medical Center, Columbus, Ohio 43210, USA. michael.firstenberg@osumc.edu
The Annals of Thoracic Surgery
|February 23, 2010
Summary
Malignant hyperthermia is a rare, potentially fatal skeletal muscle disorder. This case highlights a rare onset of malignant hyperthermia after coronary revascularization and its successful management.
Area of Science:
- Anesthesiology
- Pharmacology
- Critical Care Medicine
Background:
- Malignant hyperthermia (MH) is a rare, life-threatening hypermetabolic myopathy.
- Triggering agents, such as volatile anesthetics and succinylcholine, are well-established causes of MH.
- MH is characterized by uncontrolled muscle contraction and increased heat production.
Observation:
- A patient developed malignant hyperthermia (MH) shortly after a coronary revascularization procedure.
- The onset of MH occurred several minutes after the discontinuation of the suspected triggering agent.
- The patient's presentation was dramatic, indicating a severe hypermetabolic state.
Findings:
- This case demonstrates a rare instance of malignant hyperthermia (MH) onset.
- Successful management strategies were employed to treat the patient's MH episode.
- The clinical course underscores the importance of prompt recognition and intervention.
Implications:
- This case expands the understanding of malignant hyperthermia (MH) presentation.
- It emphasizes the need for vigilance even after triggering agent discontinuation.
- Effective management protocols for MH are crucial for patient survival.
More Related Videos
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...